Clinical trial
Medical Treatment for Diamond Blackfan Anemia
NCT00001749 · National Heart, Lung, and Blood Institute (NHLBI), NIH · Completed
Key facts
| NCT number | NCT00001749 |
|---|---|
| Title | Medical Treatment for Diamond Blackfan Anemia |
| Official title | Treatment of Diamond Blackfan Anemia With Antithymocyte Globulin and Cyclosporine A |
| Lead sponsor | National Heart, Lung, and Blood Institute (NHLBI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Fanconi's Anemia, Hematologic Disease |
| Intervention type | Drug |
| Interventions | Antithymocyte globulin, Cyclosporine |
| Enrollment | 25 |
| Start date | Jul 1, 1998 |
| Completion | Jul 1, 2005 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: